BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«QLT

Below is an extended QLT patents listing. Click here to return to the QLT main Biocorporate entry.

QLT Patents :

US Patent No.Title
5707608 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
6100290 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
6107325 Green porphyrins as immunomodulators
6117862 Model and method for angiogenesis inhibition
6146409 Therapeutic methods and devices for irradiating columnar environments
6153639 Ethylene glycol esters as photoactive agents
6180402 Method for inhibiting apoptosis induced by photodynamic therapy using a cysteine or serine protease inhibitor
6235767 Methods to treat arterial plaque
6248734 Use of photodynamic therapy for prevention of secondary cataracts
6274614 Methods, compositions and articles for reducing or preventing the effects of inflammation
6364907 Method to prevent xenograft transplant rejection
6096776 Green porphyrins as immunomodulators
6086558 Balloon catheter for photodynamic therapy
5756541 Vision through photodynamic therapy of the eye
5834503 Methods to treat arterial plaque
5882328 Method to prevent transplant rejection
5883246 Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
5910510 Vision through photodynamic therapy of the eye
5945439 Method for destroying or inhibiting growth of unwanted cells or tissues
6008241 Green porphyrins as immunomodulators
6013053 Balloon catheter for photodynamic therapy
6043237 Use of photodynamic therapy for prevention of secondary cataracts
6074666 Liposome compositions of porphyrin photosensitizers
6548542 Vision through photodynamic therapy of the eye
6599891 Treatment of macular edema
6609014 Use of PDT to inhibit intimal hyperplasia
7090691 Photodynamic therapy for the treatment of hair loss
7105503 Pyrazole compounds
7122568 Use of low-dose PDT to inhibit restenosis
7122569 Ethylene glycol esters as photoactive agents
7128927 Emulsions for in-situ delivery systems
7135193 Liposome compositions of porphyrin photosensitizers
7264629 Photodynamic therapy for the treatment of hair loss
7288556 Antiproliferative 1,2,3-thiadiazole compounds
7347480 Electromotive sunvisor assembly of a vehicle and the method thereof
7393869 Methods of using thiazolidine derivatives to treat cancer or inflammation
7060695 Method to prevent vision loss
7022702 Antiproliferative 1,2,3-thiadiazole compounds
6659107 Method to prevent xenograft transplant rejection
6677366 Methods, compositions and articles for reducing or preventing the effects of inflammation
6756396 Ethylene glycol esters as photoactive agents
6800086 Reduced fluence rate PDT
6830925 CaMK-X1 and its uses
6849058 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
6890555 Liposome compositions of porphyrin photosensitizers
6907679 Method for lyophilizing an active agent
6984395 Drug delivery system for hydrophobic drugs
7015240 Treatment of macular edema
7399462 Protectant for UV-induced skin damage

«QLT

This page contained an extended QLT patents listing. Click here to return to the QLT main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.